Ampicillin-Sulbactam for Left Pelvic Cellulitis
Yes, ampicillin-sulbactam is effective for treating left pelvic cellulitis and is specifically FDA-approved for gynecological infections including pelvic cellulitis caused by beta-lactamase producing organisms. 1
FDA-Approved Indication
Ampicillin-sulbactam is explicitly indicated for gynecological infections caused by beta-lactamase producing strains of Escherichia coli and Bacteroides species (including B. fragilis) 1. The FDA label specifically lists pelvic cellulitis as a treatable condition within its approved indications 1.
Clinical Evidence Supporting Use
The clinical data strongly supports ampicillin-sulbactam for pelvic cellulitis:
In a study of 24 women with gynecologic infections, 10 patients had pelvic cellulitis plus vaginal cuff abscess. Treatment with sulbactam/ampicillin (1g/1g IV every 6 hours for 3-4 days, then IM every 8 hours for 3-5 days) achieved cure in 22 of 24 patients (92% success rate) 2.
A comparative trial showed 19 of 20 patients (95%) with severe pelvic infections including posthysterectomy pelvic cellulitis were cured with ampicillin/sulbactam, performing equivalently to metronidazole-gentamicin 3.
Another randomized study of 44 patients with soft tissue pelvic infections (including 2 cases of posthysterectomy pelvic cellulitis) demonstrated 19 of 20 patients (95%) achieved clinical cure with ampicillin/sulbactam 4.
Microbiologic Coverage
Ampicillin-sulbactam provides appropriate coverage for the typical polymicrobial nature of pelvic cellulitis:
- Covers beta-lactamase producing anaerobes including Bacteroides fragilis and other Bacteroides species 1
- Covers aerobic gram-negative organisms like E. coli and Klebsiella species 1
- Covers gram-positive organisms including Enterococcus and streptococci 1
The studies demonstrate that pelvic infections typically yield 6-10 organisms per infection (predominantly anaerobes), and ampicillin-sulbactam successfully eradicated these mixed infections 2, 3, 4.
Dosing Recommendation
Standard dosing: 1.5-3g IV every 6 hours (equivalent to 1-2g ampicillin plus 0.5-1g sulbactam per dose) 1. The clinical studies used 1g sulbactam plus 1g ampicillin IV every 6 hours with excellent results 2.
Important Caveats
- Does NOT cover Pseudomonas aeruginosa 5 - if this organism is suspected, choose a different regimen
- Does NOT cover extended-spectrum beta-lactamase (ESBL) producing organisms 5
- Does NOT cover Chlamydia trachomatis - the one treatment failure in the comparative studies required addition of antichlamydial therapy 3
- Consider adding coverage for MRSA if suspected based on local epidemiology, though this is less common in community-acquired pelvic cellulitis
When to Use Alternative Therapy
Per IDSA guidelines for severe infections with systemic toxicity, vancomycin plus piperacillin-tazobactam or a carbapenem should be considered for severely compromised patients 6. However, for moderate severity pelvic cellulitis without septic shock or severe immunocompromise, ampicillin-sulbactam remains an excellent first-line choice based on both FDA approval and strong clinical evidence.